UCLA is one of the largest centers in the country for treating patients with PAH. PAH is defined as elevated blood pressure in the lungs, which leads to enlargement of the right side of the heart and, if untreated, heart failure and death.
Fortunately, as a result of research, including that of UCLA Pulmonary Vascular Disease physicians, there are now numerous effective treatment options for PAH. Determining which option is best for an individual patient and following patients on treatment requires an experienced team of physicians, nurse practitioners and nurses.
The diagnosis of PAH requires first recognizing suspicious symptoms. These include:
We also ask about risk factors that could make PAH more likely, including:
Once a diagnosis of PAH is considered, several tests may be performed. These include
We have developed many effective treatments for PAH. These medications range from once a day pills to infusion pumps that deliver medication continuously through an implanted catheter. Which medications are right for you will depend on a number of factors (severity of your condition, type of PH you have, tolerability in terms of side effects, etc…) The physicians and nurse practitioners in the UCLA Pulmonary Vascular Programs, all international leaders in the field, have decades of experience in treating PAH and will provide the best, state of the art care to you.
In some cases, lung transplantation may be the best option. If this is the case, we can make a referral to the UCLA lung transplant program, one of the largest in the country.